European Case Law Identifier: | ECLI:EP:BA:2000:T039697.20001115 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 15 November 2000 | ||||||||
Case number: | T 0396/97 | ||||||||
Application number: | 87902908.0 | ||||||||
IPC class: | A61K 31/78 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Novel topical metronidazole formulations | ||||||||
Applicant name: | GALDERMA S.A. | ||||||||
Opponent name: | Dr. August Wolff Chemisch Pharmazeutische Fabrik | ||||||||
Board: | 3.3.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Main request and auxiliary requests 1 and 2 - inventive step no - obvious alternative composition Auxiliary request 3 - not admissible - treatment of human body Fourth auxiliary request - not admitted into the proceedings - filed at the very end of the oral proceedings and total shifting of the invention - abuse of procedure - yes |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t970396eu1.html
Date retrieved: 17 May 2021